AMGN,BRIEF-EU Medicines Agency gives nod for Amgen's cholesterol drugAmgen first to win EU backing for new kind of cholesterol drugAmgen first to win EU backing for new kind of cholesterol drugAmgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.    Amgen first to win EU backing for new kind of cholesterol drugAmgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   May 22 Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen first to win EU backing for new kind of cholesterol drugAmgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.     Amgen first to win EU backing for new kind of cholesterol drugAmgen first to win EU backing for new kind of cholesterol drugAmgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.    Amgen first to win EU backing for new kind of cholesterol drugAmgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   May 22 Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen first to win EU backing for new kind of cholesterol drugAmgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.    * Recommends approval of cholesterol drug Repatha from Amgen IncAmgen first to win EU backing for new kind of cholesterol drugAmgen first to win EU backing for new kind of cholesterol drugAmgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.    Amgen first to win EU backing for new kind of cholesterol drugAmgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   May 22 Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen first to win EU backing for new kind of cholesterol drugAmgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.   Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  Amgen Inc's closely watched new cholesterol drug, Repatha, has been recommended for approval in Europe, putting the U.S. drugmaker ahead in a race with rival Sanofi SA.Amgen ends collaboration with AstraZeneca on inflammation drugUPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.  UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop an inflammation drug after it observed suicidal thoughts in subjects of a trial.UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22 Amgen Inc said it will terminate a collaboration with AstraZeneca Plc  to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.     
ADM,ADM scaling back global sugar trading - sourcesUPDATE 1-ADM scaling back global sugar trading - sourcesAs ethanol boom fades, ADM sees bright future for corn in grocery aisleADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes. CHICAGO, May 22 The world's largest corn processor, Archer Daniels Midland Co, is shifting focus from its long-standing cash generator ethanol into developing new food ingredients as the biofuel boom that underpinned its financial success has cooled.ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.   As ethanol boom fades, ADM sees bright future for corn in grocery aisleADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes. CHICAGO, May 22 The world's largest corn processor, Archer Daniels Midland Co, is shifting focus from its long-standing cash generator ethanol into developing new food ingredients as the biofuel boom that underpinned its financial success has cooled.ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  LONDON, May 22 U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.As ethanol boom fades, ADM sees bright future for corn in grocery aisleADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes. CHICAGO, May 22 The world's largest corn processor, Archer Daniels Midland Co, is shifting focus from its long-standing cash generator ethanol into developing new food ingredients as the biofuel boom that underpinned its financial success has cooled.ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.    UPDATE 1-ADM scaling back global sugar trading - sourcesAs ethanol boom fades, ADM sees bright future for corn in grocery aisleADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes. CHICAGO, May 22 The world's largest corn processor, Archer Daniels Midland Co, is shifting focus from its long-standing cash generator ethanol into developing new food ingredients as the biofuel boom that underpinned its financial success has cooled.ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.   As ethanol boom fades, ADM sees bright future for corn in grocery aisleADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes. CHICAGO, May 22 The world's largest corn processor, Archer Daniels Midland Co, is shifting focus from its long-standing cash generator ethanol into developing new food ingredients as the biofuel boom that underpinned its financial success has cooled.ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  LONDON, May 22 U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.As ethanol boom fades, ADM sees bright future for corn in grocery aisleADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes. CHICAGO, May 22 The world's largest corn processor, Archer Daniels Midland Co, is shifting focus from its long-standing cash generator ethanol into developing new food ingredients as the biofuel boom that underpinned its financial success has cooled.ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.   LONDON, May 22 U.S. agribusiness Archer Daniels Midland Co is scaling back its global sugar trading operations and the London-based head of that business, Alberto Peixoto, has left the company, trade sources said.UPDATE 1-ADM scaling back global sugar trading - sourcesAs ethanol boom fades, ADM sees bright future for corn in grocery aisleADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes. CHICAGO, May 22 The world's largest corn processor, Archer Daniels Midland Co, is shifting focus from its long-standing cash generator ethanol into developing new food ingredients as the biofuel boom that underpinned its financial success has cooled.ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.   As ethanol boom fades, ADM sees bright future for corn in grocery aisleADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes. CHICAGO, May 22 The world's largest corn processor, Archer Daniels Midland Co, is shifting focus from its long-standing cash generator ethanol into developing new food ingredients as the biofuel boom that underpinned its financial success has cooled.ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  LONDON, May 22 U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.As ethanol boom fades, ADM sees bright future for corn in grocery aisleADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.  ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes. CHICAGO, May 22 The world's largest corn processor, Archer Daniels Midland Co, is shifting focus from its long-standing cash generator ethanol into developing new food ingredients as the biofuel boom that underpinned its financial success has cooled.ADM scaling back global sugar trading: sources LONDON U.S. agribusiness Archer Daniels Midland Co is scaling back its modest-sized sugar trading operations and the London-based head of that business has left after less than four years, trade sources said, a sign of the sugar market's deepening woes.    
BHI,Oil edges down but WTI set for record 10th week of gainsUPDATE 7-Oil down more than 1 pct ahead of long U.S. Memorial Day weekend * Coming up: Baker Hughes rig count at 1700 GMT    (New throughout, updating market activity and comments to U.S. session; changes byline and dateline, previous LONDON)  UPDATE 7-Oil down more than 1 pct ahead of long U.S. Memorial Day weekend * Coming up: Baker Hughes rig count at 1700 GMT    (New throughout, updating market activity and comments to U.S. session; changes byline and dateline, previous LONDON) SINGAPORE, May 22 Oil prices edged down on Friday after rising more than 2 percent in the previous session, buoyed by lower U.S. crude inventories and geopolitical tension in the Middle East.UPDATE 7-Oil down more than 1 pct ahead of long U.S. Memorial Day weekend * Coming up: Baker Hughes rig count at 1700 GMT    (New throughout, updating market activity and comments to U.S. session; changes byline and dateline, previous LONDON)  
BA,BRIEF-Air China's board approves unit Shenzhen Airlines to acquire 46 Boeing planesUS STOCKS-S&P;, Dow dip after inflation rises; Yellen speech awaitedUS STOCKS-Wall St flat, Yellen comments in line with expectations * Yellen comments leave rate expectations unchanged on Wall Street  US STOCKS-Wall St flat, Yellen comments in line with expectations * Yellen comments leave rate expectations unchanged on Wall Street * Indexes: Dow down 0.24 pct, S&P; off 0.11 pct, Nasdaq up 0.08 pct   (Updates to early afternoon)US STOCKS-Wall St flat, Yellen comments in line with expectations * Yellen comments leave rate expectations unchanged on Wall Street   US STOCKS-S&P;, Dow dip after inflation rises; Yellen speech awaitedUS STOCKS-Wall St flat, Yellen comments in line with expectations * Yellen comments leave rate expectations unchanged on Wall Street  US STOCKS-Wall St flat, Yellen comments in line with expectations * Yellen comments leave rate expectations unchanged on Wall Street * Indexes: Dow down 0.24 pct, S&P; off 0.11 pct, Nasdaq up 0.08 pct   (Updates to early afternoon)US STOCKS-Wall St flat, Yellen comments in line with expectations * Yellen comments leave rate expectations unchanged on Wall Street  * Says board approves its unit Shenzhen Airlines to acquire 46 Boeing B737 planesUS STOCKS-S&P;, Dow dip after inflation rises; Yellen speech awaitedUS STOCKS-Wall St flat, Yellen comments in line with expectations * Yellen comments leave rate expectations unchanged on Wall Street  US STOCKS-Wall St flat, Yellen comments in line with expectations * Yellen comments leave rate expectations unchanged on Wall Street * Indexes: Dow down 0.24 pct, S&P; off 0.11 pct, Nasdaq up 0.08 pct   (Updates to early afternoon)US STOCKS-Wall St flat, Yellen comments in line with expectations * Yellen comments leave rate expectations unchanged on Wall Street   
BMY,Merck follows Bristol with EU green light for immune cancer drug May 22 European regulators have recommended approval of Merck & Co Inc's immune system-boosting cancer drug Keytruda, following a similar green light last month for Bristol-Myers Squibb Co's rival product Opdivo. 
CPB,Campbell Soup's quarterly sales fall 3.6 pctCORRECTED-UPDATE 1-Campbell's revenue misses as U.S. soup sales fallUPDATE 3-Campbell Soup profit beats on lower promotion costs, higher prices * Sales fall 3.6 pct to $1.90 bln   (Adds EPS guidance and context on retailer inventory movements)  UPDATE 3-Campbell Soup profit beats on lower promotion costs, higher prices * Sales fall 3.6 pct to $1.90 bln   (Adds EPS guidance and context on retailer inventory movements) May 22 Packaged foods maker Campbell Soup Co  reported lower-than-expected quarterly sales, hurt by a strong dollar and "movements in retailer inventory levels" in its U.S. soups business.UPDATE 3-Campbell Soup profit beats on lower promotion costs, higher prices * Sales fall 3.6 pct to $1.90 bln   (Adds EPS guidance and context on retailer inventory movements)   CORRECTED-UPDATE 1-Campbell's revenue misses as U.S. soup sales fallUPDATE 3-Campbell Soup profit beats on lower promotion costs, higher prices * Sales fall 3.6 pct to $1.90 bln   (Adds EPS guidance and context on retailer inventory movements)  UPDATE 3-Campbell Soup profit beats on lower promotion costs, higher prices * Sales fall 3.6 pct to $1.90 bln   (Adds EPS guidance and context on retailer inventory movements) May 22 Packaged foods maker Campbell Soup Co  reported lower-than-expected quarterly sales, hurt by a strong dollar and "movements in retailer inventory levels" in its U.S. soups business.UPDATE 3-Campbell Soup profit beats on lower promotion costs, higher prices * Sales fall 3.6 pct to $1.90 bln   (Adds EPS guidance and context on retailer inventory movements)  May 22 Campbell Soup Co, the maker of Pepperidge Farm cookies and Goldfish crackers, reported a 3.6 percent fall in quarterly sales, hurt by a strong dollar and "retailer inventory movements" in its U.S. soup business.CORRECTED-UPDATE 1-Campbell's revenue misses as U.S. soup sales fallUPDATE 3-Campbell Soup profit beats on lower promotion costs, higher prices * Sales fall 3.6 pct to $1.90 bln   (Adds EPS guidance and context on retailer inventory movements)  UPDATE 3-Campbell Soup profit beats on lower promotion costs, higher prices * Sales fall 3.6 pct to $1.90 bln   (Adds EPS guidance and context on retailer inventory movements) May 22 Packaged foods maker Campbell Soup Co  reported lower-than-expected quarterly sales, hurt by a strong dollar and "movements in retailer inventory levels" in its U.S. soups business.UPDATE 3-Campbell Soup profit beats on lower promotion costs, higher prices * Sales fall 3.6 pct to $1.90 bln   (Adds EPS guidance and context on retailer inventory movements)   
C,Citi fails to win $270 mln order vs Mercuria in metals financing caseCitigroup selling retail online FX trading platform to FXCM, Saxo Bank NEW YORK, May 22 Citigroup said on Friday it is selling its margin foreign exchange business, including the CitiFX Pro and TradeStream platforms to U.S.-based FXCM and Danish investment bank SAXO Bank.  Citigroup selling retail online FX trading platform to FXCM, Saxo Bank NEW YORK, May 22 Citigroup said on Friday it is selling its margin foreign exchange business, including the CitiFX Pro and TradeStream platforms to U.S.-based FXCM and Danish investment bank SAXO Bank. * Web of legal actions resulting from suspected fraud in ChinaCitigroup selling retail online FX trading platform to FXCM, Saxo Bank NEW YORK, May 22 Citigroup said on Friday it is selling its margin foreign exchange business, including the CitiFX Pro and TradeStream platforms to U.S.-based FXCM and Danish investment bank SAXO Bank.  
DRI,Hedge fund Barington wins fight for 2 Eastern Co board seats BOSTON, May 22 Barington Capital Group won its proxy contest by scoring two board seats at Eastern Co  this week as shareholders widely backed the activist hedge fund's call to add new blood at the industrial hardware maker. 
DE,Deere 2nd-qtr profit falls, hit by weak global agriculture sectorUPDATE 2-Deere raises 2015 profit outlook despite weak farm market CHICAGO, May 22 Deere & Co on Friday reported a higher-than-expected quarterly profit and raised its full-year outlook after cost cuts helped compensate for weakening demand for its farm equipment.  UPDATE 2-Deere raises 2015 profit outlook despite weak farm market CHICAGO, May 22 Deere & Co on Friday reported a higher-than-expected quarterly profit and raised its full-year outlook after cost cuts helped compensate for weakening demand for its farm equipment. CHICAGO, May 22 Farm equipment maker Deere & Co  posted a sharply lower quarterly net profit on Friday as a weak global agriculture sector hurt sales, but still came in handily above market expectations.UPDATE 2-Deere raises 2015 profit outlook despite weak farm market CHICAGO, May 22 Deere & Co on Friday reported a higher-than-expected quarterly profit and raised its full-year outlook after cost cuts helped compensate for weakening demand for its farm equipment.  
EXPE,Expedia sells eLong stake to Ctrip, others for $671 mlnUPDATE 1-Expedia sells eLong stake to Ctrip, others for $671 mlnExpedia sells eLong stake to Ctrip, others for $671 million Expedia Inc  said it sold its entire stake in online travel company eLong Inc  to rival Ctrip.com International Ltd  and others for about $671 million, after struggling with mounting losses at the Chinese company.  Expedia sells eLong stake to Ctrip, others for $671 million Expedia Inc  said it sold its entire stake in online travel company eLong Inc  to rival Ctrip.com International Ltd  and others for about $671 million, after struggling with mounting losses at the Chinese company. May 22 Expedia Inc said it sold its entire stake in online travel company eLong Inc to rival Ctrip.com International Ltd and others for about $671 million, after struggling with mounting losses at the Chinese company.Expedia sells eLong stake to Ctrip, others for $671 million Expedia Inc  said it sold its entire stake in online travel company eLong Inc  to rival Ctrip.com International Ltd  and others for about $671 million, after struggling with mounting losses at the Chinese company.   UPDATE 1-Expedia sells eLong stake to Ctrip, others for $671 mlnExpedia sells eLong stake to Ctrip, others for $671 million Expedia Inc  said it sold its entire stake in online travel company eLong Inc  to rival Ctrip.com International Ltd  and others for about $671 million, after struggling with mounting losses at the Chinese company.  Expedia sells eLong stake to Ctrip, others for $671 million Expedia Inc  said it sold its entire stake in online travel company eLong Inc  to rival Ctrip.com International Ltd  and others for about $671 million, after struggling with mounting losses at the Chinese company. May 22 Expedia Inc said it sold its entire stake in online travel company eLong Inc to rival Ctrip.com International Ltd and others for about $671 million, after struggling with mounting losses at the Chinese company.Expedia sells eLong stake to Ctrip, others for $671 million Expedia Inc  said it sold its entire stake in online travel company eLong Inc  to rival Ctrip.com International Ltd  and others for about $671 million, after struggling with mounting losses at the Chinese company.  May 22 Expedia Inc said it sold its entire stake in Chinese online travel company eLong Inc  to rival Ctrip.com International Ltd and others for about $671 million.UPDATE 1-Expedia sells eLong stake to Ctrip, others for $671 mlnExpedia sells eLong stake to Ctrip, others for $671 million Expedia Inc  said it sold its entire stake in online travel company eLong Inc  to rival Ctrip.com International Ltd  and others for about $671 million, after struggling with mounting losses at the Chinese company.  Expedia sells eLong stake to Ctrip, others for $671 million Expedia Inc  said it sold its entire stake in online travel company eLong Inc  to rival Ctrip.com International Ltd  and others for about $671 million, after struggling with mounting losses at the Chinese company. May 22 Expedia Inc said it sold its entire stake in online travel company eLong Inc to rival Ctrip.com International Ltd and others for about $671 million, after struggling with mounting losses at the Chinese company.Expedia sells eLong stake to Ctrip, others for $671 million Expedia Inc  said it sold its entire stake in online travel company eLong Inc  to rival Ctrip.com International Ltd  and others for about $671 million, after struggling with mounting losses at the Chinese company.   
XOM,DIARY-U.S. MEETINGS/WEEK AHEAD Thomson Reuters May 22, 2015 - Corporate Meetings for US companies for Week ahead.         S&P; 500 Earnings - MONTH AHEAD     Dividends                            Non S&P; 500 - Weekly             Federal Reserve events               ConferenceCall/Webcast - Weekly  Meetings - Weekly                                Xtra users can see more details on conference calls & webcasts by hovering your mouse  over the RIC, right click, no click on Related Co Data, now click on Co Events.             ** For 
FB,Founder of Facebook's Oculus hit with lawsuit SAN FRANCISCO, May 22 The founder of virtual reality glasses maker Oculus VR Inc, acquired by Facebook Inc  for $2 billion, has been accused of taking confidential information he learned while working with another company and passing it off as his own, according to a lawsuit filed this week. 
HPQ,UPDATE 3-HP forecasts split-related costs below expectationsHP forecasts split-related costs below expectationsHP sells $2.3 bln China unit stake to forge partnership with Tsinghua UnigroupHP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  HONG KONG, May 22 Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)    HP sells $2.3 bln China unit stake to forge partnership with Tsinghua UnigroupHP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  HONG KONG, May 22 Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   Hewlett-Packard Co , which is in the process of splitting itself, forecast separation-related costs below the expectation of several analysts and reported a better-than-expected quarterly profit.HP sells $2.3 bln China unit stake to forge partnership with Tsinghua UnigroupHP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  HONG KONG, May 22 Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)     HP forecasts split-related costs below expectationsHP sells $2.3 bln China unit stake to forge partnership with Tsinghua UnigroupHP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  HONG KONG, May 22 Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)    HP sells $2.3 bln China unit stake to forge partnership with Tsinghua UnigroupHP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  HONG KONG, May 22 Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   Hewlett-Packard Co , which is in the process of splitting itself, forecast separation-related costs below the expectation of several analysts and reported a better-than-expected quarterly profit.HP sells $2.3 bln China unit stake to forge partnership with Tsinghua UnigroupHP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  HONG KONG, May 22 Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)    May 21 Hewlett-Packard Co, which is in the process of splitting itself, forecast separation-related costs below the expectation of several analysts and reported a better-than-expected quarterly profit.HP forecasts split-related costs below expectationsHP sells $2.3 bln China unit stake to forge partnership with Tsinghua UnigroupHP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  HONG KONG, May 22 Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)    HP sells $2.3 bln China unit stake to forge partnership with Tsinghua UnigroupHP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  HONG KONG, May 22 Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   Hewlett-Packard Co , which is in the process of splitting itself, forecast separation-related costs below the expectation of several analysts and reported a better-than-expected quarterly profit.HP sells $2.3 bln China unit stake to forge partnership with Tsinghua UnigroupHP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)   HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  HONG KONG, May 22 Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.HP sells $2.3 billion China unit stake to forge partnership with Tsinghua UnigroupUS STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)  US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment) HONG KONG Hewlett-Packard Co  will sell a controlling 51 percent stake in its China-based data-networking business to China's Tsinghua Unigroup for at least $2.3 billion, forming a partnership designed to create a Chinese technology powerhouse.US STOCKS-Wall St mixed as CPI data sparks rate hike timing doubts * Indexes: Dow down 0.13 pct, S&P; off 0.05 pct, Nasdaq up 0.16 pct   (Updates to open, adds comment)     
MA,MasterCard, Target fail to reach settlement on 2013 data breachUPDATE 1-MasterCard, Target data breach settlement falls apartMasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.  MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday. May 22 A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.   UPDATE 1-MasterCard, Target data breach settlement falls apartMasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.  MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday. May 22 A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.  May 22 MasterCard Inc, the world's No. 2 debit and credit card company, said it failed to reach a settlement with Target Corp over claims related to the 2013 data breach at the retailer as a key condition was not met.UPDATE 1-MasterCard, Target data breach settlement falls apartMasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.  MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday. May 22 A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.   
MRK,Merck follows Bristol with EU green light for immune cancer drug May 22 European regulators have recommended approval of Merck & Co Inc's immune system-boosting cancer drug Keytruda, following a similar green light last month for Bristol-Myers Squibb Co's rival product Opdivo. 
MSFT,HP forecasts split-related costs below expectationsMicrosoft, Salesforce held "significant" talks this spring - CNBCUS STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.    US STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   May 22 Microsoft Corp held "significant" talks with Salesforce.com Inc this spring and was willing to offer about $55 billion for the company, CNBC reported, citing people familiar with the situation. (http://cnb.cx/1IPBIkG)     (Reporting by Anya George Tharakan in Bengaluru; Editing by Kirti Pandey)US STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.     Microsoft, Salesforce held "significant" talks this spring - CNBCUS STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.    US STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   May 22 Microsoft Corp held "significant" talks with Salesforce.com Inc this spring and was willing to offer about $55 billion for the company, CNBC reported, citing people familiar with the situation. (http://cnb.cx/1IPBIkG)     (Reporting by Anya George Tharakan in Bengaluru; Editing by Kirti Pandey)US STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.    Hewlett-Packard Co , which is in the process of splitting itself, forecast separation-related costs below the expectation of several analysts and reported a better-than-expected quarterly profit.Microsoft, Salesforce held "significant" talks this spring - CNBCUS STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.    US STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   May 22 Microsoft Corp held "significant" talks with Salesforce.com Inc this spring and was willing to offer about $55 billion for the company, CNBC reported, citing people familiar with the situation. (http://cnb.cx/1IPBIkG)     (Reporting by Anya George Tharakan in Bengaluru; Editing by Kirti Pandey)US STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.     
MON,ChemChina says not considering bids for Monsanto's herbicide business, SyngentaChemChina says not considering bids for Monsanto's herbicide business, SyngentaChemChina says not considering bids for Monsanto's herbicide business, SyngentaMonsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds. BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's herbicide business or for Swiss crop chemicals maker Syngenta, a top ChemChina executive told Reuters on Friday.Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.   ChemChina says not considering bids for Monsanto's herbicide business, SyngentaMonsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds. BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's herbicide business or for Swiss crop chemicals maker Syngenta, a top ChemChina executive told Reuters on Friday.Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's  herbicide business or for Swiss crop chemicals maker Syngenta , a top ChemChina executive told Reuters on Friday.ChemChina says not considering bids for Monsanto's herbicide business, SyngentaMonsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds. BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's herbicide business or for Swiss crop chemicals maker Syngenta, a top ChemChina executive told Reuters on Friday.Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.    ChemChina says not considering bids for Monsanto's herbicide business, SyngentaChemChina says not considering bids for Monsanto's herbicide business, SyngentaMonsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds. BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's herbicide business or for Swiss crop chemicals maker Syngenta, a top ChemChina executive told Reuters on Friday.Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.   ChemChina says not considering bids for Monsanto's herbicide business, SyngentaMonsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds. BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's herbicide business or for Swiss crop chemicals maker Syngenta, a top ChemChina executive told Reuters on Friday.Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's  herbicide business or for Swiss crop chemicals maker Syngenta , a top ChemChina executive told Reuters on Friday.ChemChina says not considering bids for Monsanto's herbicide business, SyngentaMonsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds. BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's herbicide business or for Swiss crop chemicals maker Syngenta, a top ChemChina executive told Reuters on Friday.Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.   BEIJING, May 22 State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's herbicide business or for Swiss crop chemicals maker Syngenta, a top ChemChina executive told Reuters on Friday.ChemChina says not considering bids for Monsanto's herbicide business, SyngentaChemChina says not considering bids for Monsanto's herbicide business, SyngentaMonsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds. BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's herbicide business or for Swiss crop chemicals maker Syngenta, a top ChemChina executive told Reuters on Friday.Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.   ChemChina says not considering bids for Monsanto's herbicide business, SyngentaMonsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds. BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's herbicide business or for Swiss crop chemicals maker Syngenta, a top ChemChina executive told Reuters on Friday.Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's  herbicide business or for Swiss crop chemicals maker Syngenta , a top ChemChina executive told Reuters on Friday.ChemChina says not considering bids for Monsanto's herbicide business, SyngentaMonsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.  Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds. BEIJING State-owned China National Chemical Corp, better known as ChemChina, is not considering bidding for Monsanto's herbicide business or for Swiss crop chemicals maker Syngenta, a top ChemChina executive told Reuters on Friday.Monsanto's move on Syngenta could mean move away from glyphosate May 22 Monsanto Co, the world's largest seed company, is also known for the popularity of its Roundup herbicide, a weedkiller beloved by farmers and homeowners alike for its speed and deadly assault on tough weeds.    
DGX,Quest Diagnostics shares up on takeover speculation NEW YORK, May 22 Quest Diagnostics Inc  shares jumped on heavy volume on Friday following chatter on Twitter and elsewhere that the lab testing company may be trying to sell itself. 
CRM,Microsoft, Salesforce held "significant" talks this spring - CNBCUS STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.    US STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   May 22 Microsoft Corp held "significant" talks with Salesforce.com Inc this spring and was willing to offer about $55 billion for the company, CNBC reported, citing people familiar with the situation. (http://cnb.cx/1IPBIkG)     (Reporting by Anya George Tharakan in Bengaluru; Editing by Kirti Pandey)US STOCKS-Wall St flat, Yellen comments in line with expectationsUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.   UPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  * Yellen comments leave rate expectations unchanged on Wall StreetUPDATE 2-Microsoft, Salesforce talks fell through on pricing - CNBCMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.  Microsoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter. * Potential bidder can go up to $70 bln on high end - analystMicrosoft, Salesforce talks fell through on pricing: CNBC Microsoft Corp  and Salesforce.com Inc  held "significant talks" this spring but failed to agree on a price, CNBC reported, citing people familiar with the matter.    
TGT,MasterCard, Target fail to reach settlement on 2013 data breachUPDATE 1-MasterCard, Target data breach settlement falls apartMasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.  MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday. May 22 A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.   UPDATE 1-MasterCard, Target data breach settlement falls apartMasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.  MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday. May 22 A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.  May 22 MasterCard Inc, the world's No. 2 debit and credit card company, said it failed to reach a settlement with Target Corp over claims related to the 2013 data breach at the retailer as a key condition was not met.UPDATE 1-MasterCard, Target data breach settlement falls apartMasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.  MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday. May 22 A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.MasterCard, Target data breach settlement falls apart A proposed $19 million settlement between MasterCard Inc and Target Corp over the retailer's 2013 data breach fell through after not enough banks accepted the deal, the credit card company said on Thursday.   
WMT,Wal-Mart U.S. asking meat suppliers to reduce antibiotic useWal-Mart urges meat suppliers to curb antibiotic useUPDATE 3-Wal-Mart urges meat suppliers to curb antibiotic use CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take such a public stand against the excessive use of drugs in raising farm animals.  UPDATE 3-Wal-Mart urges meat suppliers to curb antibiotic use CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take such a public stand against the excessive use of drugs in raising farm animals. CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take a stand against the excessive use of drugs in raising farm animals.UPDATE 3-Wal-Mart urges meat suppliers to curb antibiotic use CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take such a public stand against the excessive use of drugs in raising farm animals.   Wal-Mart urges meat suppliers to curb antibiotic useUPDATE 3-Wal-Mart urges meat suppliers to curb antibiotic use CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take such a public stand against the excessive use of drugs in raising farm animals.  UPDATE 3-Wal-Mart urges meat suppliers to curb antibiotic use CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take such a public stand against the excessive use of drugs in raising farm animals. CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take a stand against the excessive use of drugs in raising farm animals.UPDATE 3-Wal-Mart urges meat suppliers to curb antibiotic use CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take such a public stand against the excessive use of drugs in raising farm animals.  May 22 Wal-Mart Stores Inc said its U.S. units were asking meat suppliers to reduce the use of antibiotics in farm animals and provide annual reports on antibiotics management and animal welfare.Wal-Mart urges meat suppliers to curb antibiotic useUPDATE 3-Wal-Mart urges meat suppliers to curb antibiotic use CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take such a public stand against the excessive use of drugs in raising farm animals.  UPDATE 3-Wal-Mart urges meat suppliers to curb antibiotic use CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take such a public stand against the excessive use of drugs in raising farm animals. CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take a stand against the excessive use of drugs in raising farm animals.UPDATE 3-Wal-Mart urges meat suppliers to curb antibiotic use CHICAGO, May 22 Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take such a public stand against the excessive use of drugs in raising farm animals.   
